Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimotuzumab Combined with Radiotherapy for Elderly Locally Advanced SCCHN
NCT01393184Phase 2Unknown
- Sponsor
- Peking University
- Start
- Mar 2011
- Primary completion
- Feb 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of nimotuzumab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Peking University. Status: unknown.
02
Drugs
nimotuzumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01393184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393184.